Daiane K. Cecconello
Porto Alegre, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacogenetic markers of PEG-asparaginase toxicity in Brazilian pediatric ALL: insights from a multicenter prospective cohort study.
Journal: Pharmacogenomics
Published: November 13, 2025
Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences.
Journal: Pharmaceutics
Published: July 18, 2024
Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 24, 2024
Follow our path with asparaginase activity: one technique, but different uses in clinical practice.
Journal: Experimental hematology & oncology
Published: June 29, 2022
Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia.
Journal: Pediatric blood & cancer
Published: July 30, 2021
Influence of different asparaginase formulations in the prognosis of children with acute lymphocytic leukaemia in Brazil: a multicentre, retrospective controlled study.
Journal: British journal of haematology
Published: February 11, 2021
Asparaginase: an old drug with new questions.
Journal: Hematology, transfusion and cell therapy
Published: March 19, 2019
Monitoring asparaginase activity in middle-income countries.
Journal: The Lancet. Oncology
Published: July 27, 2018
Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
Journal: Anais da Academia Brasileira de Ciencias
Published: March 19, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026